Overexpression of BLK can inhibit NSCLC growth by activating the apoptosis pathway, inhibiting the G2M checkpoint, and suppressing the glycolysis pathway (Xu et al., 2023). The gene discussed is BLK; the disease is non-small cell lung carcinoma.